AIMC Topic: Neoplasms

Clear Filters Showing 1 to 10 of 2118 articles

RareNet: a deep learning model for rare cancer diagnosis.

Scientific reports
Although significant advances have been made in the early detection of many cancers, challenges remain in the early diagnosis of rare cancers, including Wilms tumor, Clear Cell Sarcoma of the Kidney, Neuroblastoma, Osteosarcoma, and Acute Myeloid Leu...

Deep learning-driven drug response prediction and mechanistic insights in cancer genomics.

Scientific reports
In the field of cancer therapy, the diversity and heterogeneity of cancer genomes in clinical patients complicate and challenge the effective use of non-targeted drugs, as these drugs often fail to address specific genetic events. Recent advancements...

A genotype-to-drug diffusion model for generation of tailored anti-cancer small molecules.

Nature communications
Despite advances in precision oncology, developing effective cancer therapeutics remains a significant challenge due to tumor heterogeneity and the limited availability of well-defined drug targets. Recent progress in generative artificial intelligen...

Unraveling the role of perineural invasion in cancer progression across multiple tumor types.

Medical oncology (Northwood, London, England)
Perineural invasion (PNI) refers to the infiltration of tumor cells into the connective tissue of nerves and is increasingly recognized as a pathological hallmark of multiple cancers, including pancreatic, prostate, colorectal, breast, and head and n...

Neural network prediction model based on Levy flight and natural biomimetic technology for its application in cancer prediction.

PloS one
Precise forecasting of cancer outcomes is essential for medical professionals to assess the well-being of patients and develop customized therapeutic plans. Despite its importance, achieving precise forecasts remains a formidable challenge. To tackle...

Emerging Trends in Point-of-Care Technology Development for Oncology in Low- and Middle-Income Countries.

JCO global oncology
The growing cancer burden and suboptimal diagnostic capacity in low- and middle-income countries calls for urgent innovation in diagnostic solutions. Point-of-care technologies (POCTs) offer a transformative approach to decentralizing cancer diagnost...

Functional Characterization of Variants of Unknown Significance of Fibroblast Growth Factor Receptors 1-4 and Comparison With AI Model-Based Prediction.

JCO precision oncology
PURPOSE: Fibroblast growth factor receptors (FGFRs; FGFR1, FGFR2, FGFR3, FGFR4) are frequently mutated oncogenes in solid cancers. The oncogenic potential of FGFR rearrangements and few hotspot point mutations is well established, but the majority of...

Next-generation cancer therapeutics: unveiling the potential of liposome-based nanoparticles through bioinformatics.

Mikrochimica acta
Cancer remains one of the most deadly diseases in the world, requiring constant growth and improvements in therapeutic strategies. Traditional cancer treatments, such as chemotherapy, radiotherapy, and surgery, have limitations like off-target releas...

Artificial Intelligence in cancer epigenomics: a review on advances in pan-cancer detection and precision medicine.

Epigenetics & chromatin
DNA methylation is a fundamental epigenetic modification that regulates gene expression and maintains genomic stability. Consequently, DNA methylation remains a key biomarker in cancer research, playing a vital role in diagnosis, prognosis, and tailo...

Classifying Stereotactic Radiosurgery Patients by Primary Diagnosis Using Natural Language Processing of Clinical Notes.

JCO clinical cancer informatics
PURPOSE: Accurate identification of the primary tumor diagnosis of patients who have undergone stereotactic radiosurgery (SRS) from electronic health records is a critical but challenging task. Traditional methods of identifying the primary tumor his...